Gadolinium Deposition and Liver MRI.
作者信息
Marks Robert M, Ash Ryan M, Lee James T
机构信息
Department of Radiology Naval Medical Center San Diego San Diego CA.
Department of Radiology Uniformed Services University of the Health Sciences Bethesda MD.
出版信息
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):129-132. doi: 10.1002/cld.1024. eCollection 2021 Mar.
Abstract
摘要
相似文献
1
Gadolinium Deposition and Liver MRI.钆沉积与肝脏磁共振成像
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):129-132. doi: 10.1002/cld.1024. eCollection 2021 Mar.
2
Gadolinium Deposition in Neurology Clinical Practice.钆在神经病学临床实践中的沉积
Ochsner J. 2019 Spring;19(1):17-25. doi: 10.31486/toj.18.0111.
3
Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).肾损伤大鼠暴露于不同钆基 MRI 对比剂后的组织钆沉积：电感耦合等离子体质谱法（ICP-MS）评估。
Magn Reson Imaging. 2013 Oct;31(8):1412-7. doi: 10.1016/j.mri.2013.03.025. Epub 2013 Apr 30.
4
Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.多次给予钆基造影剂后钆在齿状核和苍白球中的沉积——现状
Neuroradiology. 2016 May;58(5):433-41. doi: 10.1007/s00234-016-1658-1. Epub 2016 Feb 12.
5
The use of gadolinium-based contrast agents in Ghana with a focus on residual intracranial gadolinium deposition.以加纳钆基造影剂的使用为重点，关注颅内钆残留沉积情况。
Radiography (Lond). 2018 Aug;24(3):e51-e55. doi: 10.1016/j.radi.2017.12.009. Epub 2017 Dec 30.
6
Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.肝硬化患者能否在不使用钆的情况下对肝细胞癌进行成像？：采用肝脏移植标准，对比联合T2加权、T2*加权和扩散加权磁共振成像与钆增强磁共振成像。
J Comput Assist Tomogr. 2011 Nov-Dec;35(6):711-5. doi: 10.1097/RCT.0b013e31823421ac.
7
Characterization of hyperintense nodules on T1-weighted liver magnetic resonance imaging: comparison of Ferucarbotran-enhanced MRI with accumulation-phase FS-T1WI and gadolinium-enhanced MRI.肝脏 T1 加权磁共振成像上高信号结节的特征：Ferucarbotran 增强 MRI 与积相 FS-T1WI 和钆增强 MRI 的比较。
J Chin Med Assoc. 2011 Feb;74(2):62-8. doi: 10.1016/j.jcma.2011.01.013. Epub 2011 Feb 12.
8
Evaluation of Gadolinium Deposition in the Brain After MR Arthrography.磁共振关节造影后脑内钆沉积的评估。
AJR Am J Roentgenol. 2018 Nov;211(5):1063-1067. doi: 10.2214/AJR.18.19833. Epub 2018 Aug 14.
9
Gadolinium-based contrast agents - what is the evidence for 'gadolinium deposition disease' and the use of chelation therapy?镧系元素类对比剂——“镧系元素沉积病”的证据和螯合疗法的应用是什么？
Clin Toxicol (Phila). 2020 Mar;58(3):151-160. doi: 10.1080/15563650.2019.1681442. Epub 2019 Oct 30.
10
The Impact of Gadolinium Deposition on Radiology Practice: An International Survey of Radiologists.钆沉积对放射学实践的影响：放射科医生的国际调查。
Curr Probl Diagn Radiol. 2019 May-Jun;48(3):220-223. doi: 10.1067/j.cpradiol.2018.02.003. Epub 2018 Feb 7.
引用本文的文献
1
Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration.钆：造影剂给药后在人体和实验动物中的药代动力学和毒性。
Arch Toxicol. 2022 Feb;96(2):403-429. doi: 10.1007/s00204-021-03189-8. Epub 2022 Jan 8.
本文引用的文献
1
Gadolinium Deposition and Nephrogenic Systemic Fibrosis: A Radiologist's Primer.钆沉积与肾源性系统性纤维化：放射科医生入门。
Radiographics. 2020 Jan-Feb;40(1):153-162. doi: 10.1148/rg.2020190110. Epub 2019 Dec 6.
2
Gadolinium Deposition Disease: A New Risk Management Threat.钆沉积病：一种新的风险管理威胁。
J Am Coll Radiol. 2020 Apr;17(4):546-550. doi: 10.1016/j.jacr.2019.11.009. Epub 2019 Nov 27.
3
Effect of different doses of gadolinium contrast agent on clinical outcomes in MS.不同剂量钆对比剂对多发性硬化症临床结局的影响。
Mult Scler J Exp Transl Clin. 2019 Feb 16;5(1):2055217318823796. doi: 10.1177/2055217318823796. eCollection 2019 Jan-Mar.
4
Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI-RADS).钆塞酸二钠在慢性肝病患者中的应用及其对肝脏影像报告和数据系统（LI-RADS）的影响。
J Magn Reson Imaging. 2019 May;49(5):1236-1252. doi: 10.1002/jmri.26540. Epub 2019 Jan 4.
5
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.肝细胞癌的诊断、分期及管理：美国肝病研究协会2018年实践指南
Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.
6
Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study.钆基造影剂在多发性硬化症中的潴留：一项长达18年的纵向研究的回顾性分析。
AJNR Am J Neuroradiol. 2017 Jul;38(7):1311-1316. doi: 10.3174/ajnr.A5211. Epub 2017 May 11.
7
Gadolinium-based contrast agents: A comprehensive risk assessment.镧系元素类对比剂：全面风险评估。
J Magn Reson Imaging. 2017 Aug;46(2):338-353. doi: 10.1002/jmri.25625. Epub 2017 Jan 13.
8
Do Gadolinium-Based Contrast Agents Affect F-FDG PET/CT Uptake in the Dentate Nucleus and the Globus Pallidus? A Pilot Study.钆基造影剂会影响齿状核和苍白球中的F-FDG PET/CT摄取吗？一项初步研究。
J Nucl Med Technol. 2017 Mar;45(1):30-33. doi: 10.2967/jnmt.116.180844. Epub 2016 Nov 10.
9
Association Between Gadolinium Contrast Exposure and the Risk of Parkinsonism.钆造影剂暴露与帕金森综合征风险之间的关联
JAMA. 2016 Jul 5;316(1):96-8. doi: 10.1001/jama.2016.8096.
10
Hepatic Gadolinium Deposition and Reversibility after Contrast Agent-enhanced MR Imaging of Pediatric Hematopoietic Stem Cell Transplant Recipients.儿童造血干细胞移植受者对比增强磁共振成像后肝钆沉积及可逆性。
Radiology. 2016 Nov;281(2):418-426. doi: 10.1148/radiol.2016152846. Epub 2016 Jun 8.
Zotero 插件